Endovascular treatment of superior vena cava syndrome: What to be aware off

Conservative management of superior vena cava injury due to hemodialysis catheter placement: A case report and literature review

We reported the case of a 78-year old woman with the inadvertent superior vena cava injury resulting from hemodialysis catheter placement. The catheter was placed through the left internal jugular vein. Hemodynamics were stable. The initial chest film illustrated an extraluminal catheter and mediastinal widening. The patient did not have hemothorax. Computed tomography venography also confirmed...

Mediastinal Neuroendocrine Carcinoma of Unknown Origin Presenting with Superior Vena Cava Syndrome (SVCS): A Case Report

Primary neuroendocrine carcinoma (NEC) of the mediastinum is a rare type of carcinoma. According to the literature, only five cases of this condition have been reported so far. In this paper, we present a rare case of mediastinal NEC of unknown primary site. The patient was a 34-year-old man with mediastinal NEC, who presented with chronic dry cough and a right-sided mediastinal mass one year p...

Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome.

BACKGROUND Superior vena cava syndrome management has been traditionally radiation therapy, chemotherapy or chemoradiation, depending on the underlying malignancy involved and individual clinicopathological features of the case. Recent emergence of endovascular stents offer the opportunity for immediate relief of the venous stenosis. This review examines findings from the published series which...

Antiphospholipid Syndrome Presenting with Superior Vena Cava Thrombosis

Endovascular treatment of superior vena cava syndrome. A systematic review

Results The most frequent cause of superior vena cava syndrome was lung cancer. Endovascular treatment of the syndrome was accomplished via stent placement with or without angioplasty. The technical success of the method was very high (96.75%) and the corresponding clinical success was similarly high (94%). Primary patency was 87.4% on average, while secondary patency was 93.5%. The rate of syn...